Chelsea and Westminster Hospital pioneers autonomous artificial intelligence (AI) pathway for skin cancer to discharge harmless cases
Posted:
Chelsea and Westminster Hospital NHS Foundation Trust is utilising digital innovation and world-first autonomous technology to identify harmless (benign) skin lesions without review from the dermatology team, to be able to discharge patients on the same day as they receive their results.
This advanced AI skin cancer pathway helps clinicians and dermatologists effectively triage patients, enabling earlier detection.
OpenAI is expanding ChatGPT's healthcare capabilities with a new integration that connects Epic electronic health records (EHRs) to ChatGPT for Healthcare and a plugin that gives care providers access to public healthcare data sources.
The Epic integration lets clinicians bring patient information into…
Updated migraine prevention guidance incorporates calcitonin gene-related peptide (CGRP)-targeted therapies and places greater emphasis on individualized treatment selection based on patient priorities.
Preventive therapy should be offered to those with at least 4 migraine days per month, at least 4 moderate-to-severe headache days per…
Attendees
Sponsors and Exhibitors
Contact us